Skip to content

Split Dose Golytely With Amitiza Pretreatment Versus Split Dose Golytely Plus Placebo in Outpatient Colonoscopy

Single Dose Lubiprostone Along With Split-dose PEG Solution Without Dietary Restrictions for Bowel Cleansing Prior to Colonoscopy, a Randomized, Double-blind, Placebo Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00611442
Enrollment
191
Registered
2008-02-11
Start date
2007-10-31
Completion date
2008-01-31
Last updated
2012-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Preparation for Colonoscopy

Brief summary

The primary outcomes of this procedure will be: 1. The cleanliness of the prep as measured by the Ottawa Scale (attachment a). Secondary outcomes will be: 1. Patient satisfaction with the prep measured by 5 point Likert scale (attachment b); 2. Procedure time; 3. The number and size of polyps detected on examination.

Interventions

DRUGlubiprostone

lubiprostone 24mcg gelcap, 1 gelcap taken at noon the day prior to the colonoscopy

DRUGplacebo

placebo gelcap, taken at noon the day prior to the colonoscopy

Sponsors

Takeda
CollaboratorINDUSTRY
Brooke Army Medical Center
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult patients referred to our clinic for Average or Increased Risk screening for Colorectal Cancer * Ages will be from 18 years of age and older

Exclusion criteria

* Chronic kidney disease * Previous diagnosis of congestive heart failure * History of bowel obstruction * History of solid organ transplant * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
The Overall Cleanliness of the Prep as Measured by the Ottawa Scalemeasured upon completion of the colonoscopy, colonoscopies completed during the course of the study (approximately 4 month period)Bowel cleansing was evaluated with the Ottawa bowel preparation scale by each endoscopist during the endoscopy. Neither the endoscopist nor the endoscopy nurse was aware of the bowel preparation used prior to the colonoscopy. The Ottawa bowel preparation scale is a validated tool and was used in this study to provide a reliable quality assessment of the bowel preparation used for colonoscopy. This validated scale rates each section of the colon, the right, the mid, and the rectosigmoid colon, on a 5-point scale (0-4), as well as a global 3-point rating for overall colonic fluid (0-2). The total score ranges from 0 to 14. An excellent preparation with little fluid would score 0-3, a good preparation 4-6, while scores higher than 7would indicate progressively worsening bowel preparations. A completely unprepared colon would score 11-14, depending on the amount of colonic fluid

Secondary

MeasureTime frameDescription
Patient Satisfaction With the Prep Measured by 5 Point Likert Scalemeasured after completion of the bowel preparation and prior to the colonoscopy, completed during the course of the study (approximately 4 month period)The participants completed a survey prior to the colonoscopy that graded their overall satisfaction with the bowel preparation. The subjects rated the survey questions on a 5-point Likert scale where 1 = severely distressing, 2=distressing, 3=bothersome, 4=mild, and 5=none.
Procedure Timemeasured upon completion of the colonoscopy, colonoscopies completed during the course of the study (approximately 4 month period)Procedure time refers to the total length of time required to complete the colonoscopy
The Number of Polyps Detected on Examinationmeasured upon completion of the colonoscopy, colonoscopies completed during the course of the study (approximately 4 month period)The number of colon polyps detected during the colonoscopy.

Countries

United States

Participant flow

Recruitment details

Gastroenterology Clinic, Brooke Army Medical Center, Fort Sam Houston, TX October 2007 to January 2008

Participants by arm

ArmCount
Amitiza
split-dose PEG solution without dietary restrictions plus lubiprostone 24mcg gelcap pretreatment
95
Placebo
split-dose PEG solution without dietary restrictions plus placebo pretreatment
96
Total191

Baseline characteristics

CharacteristicPlaceboAmitizaTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants1 Participants1 Participants
Age, Categorical
Between 18 and 65 years
96 Participants94 Participants190 Participants
Age Continuous55.9 years
STANDARD_DEVIATION 4.8
55.4 years
STANDARD_DEVIATION 5.2
55.5 years
STANDARD_DEVIATION 5
Region of Enrollment
United States
96 participants95 participants191 participants
Sex: Female, Male
Female
45 Participants48 Participants93 Participants
Sex: Female, Male
Male
51 Participants47 Participants98 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 940 / 94
serious
Total, serious adverse events
0 / 940 / 94

Outcome results

Primary

The Overall Cleanliness of the Prep as Measured by the Ottawa Scale

Bowel cleansing was evaluated with the Ottawa bowel preparation scale by each endoscopist during the endoscopy. Neither the endoscopist nor the endoscopy nurse was aware of the bowel preparation used prior to the colonoscopy. The Ottawa bowel preparation scale is a validated tool and was used in this study to provide a reliable quality assessment of the bowel preparation used for colonoscopy. This validated scale rates each section of the colon, the right, the mid, and the rectosigmoid colon, on a 5-point scale (0-4), as well as a global 3-point rating for overall colonic fluid (0-2). The total score ranges from 0 to 14. An excellent preparation with little fluid would score 0-3, a good preparation 4-6, while scores higher than 7would indicate progressively worsening bowel preparations. A completely unprepared colon would score 11-14, depending on the amount of colonic fluid

Time frame: measured upon completion of the colonoscopy, colonoscopies completed during the course of the study (approximately 4 month period)

ArmMeasureValue (MEAN)
AmitizaThe Overall Cleanliness of the Prep as Measured by the Ottawa Scale4.8 Ottawa Score
PlaceboThe Overall Cleanliness of the Prep as Measured by the Ottawa Scale6.2 Ottawa Score
Secondary

Patient Satisfaction With the Prep Measured by 5 Point Likert Scale

The participants completed a survey prior to the colonoscopy that graded their overall satisfaction with the bowel preparation. The subjects rated the survey questions on a 5-point Likert scale where 1 = severely distressing, 2=distressing, 3=bothersome, 4=mild, and 5=none.

Time frame: measured after completion of the bowel preparation and prior to the colonoscopy, completed during the course of the study (approximately 4 month period)

ArmMeasureValue (MEAN)Dispersion
AmitizaPatient Satisfaction With the Prep Measured by 5 Point Likert Scale3.7 linkert scale (1-5)Standard Deviation 1
PlaceboPatient Satisfaction With the Prep Measured by 5 Point Likert Scale3.2 linkert scale (1-5)Standard Deviation 1.1
Secondary

Procedure Time

Procedure time refers to the total length of time required to complete the colonoscopy

Time frame: measured upon completion of the colonoscopy, colonoscopies completed during the course of the study (approximately 4 month period)

ArmMeasureValue (MEAN)Dispersion
AmitizaProcedure Time17.8 minutesStandard Deviation 5.4
PlaceboProcedure Time19.8 minutesStandard Deviation 6.2
Secondary

The Number of Polyps Detected on Examination

The number of colon polyps detected during the colonoscopy.

Time frame: measured upon completion of the colonoscopy, colonoscopies completed during the course of the study (approximately 4 month period)

ArmMeasureValue (NUMBER)
AmitizaThe Number of Polyps Detected on Examination48 number of polyps
PlaceboThe Number of Polyps Detected on Examination44 number of polyps

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026